These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35178780)

  • 21. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.
    Bouckaert F; Emsell L; Vansteelandt K; De Winter FL; Van den Stock J; Obbels J; Dols A; Stek M; Adamczuk K; Sunaert S; Van Laere K; Sienaert P; Vandenbulcke M
    J Affect Disord; 2019 May; 251():114-120. PubMed ID: 30921594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.
    Gatchel JR; Rabin JS; Buckley RF; Locascio JJ; Quiroz YT; Yang HS; Vannini P; Amariglio RE; Rentz DM; Properzi M; Donovan NJ; Blacker D; Johnson KA; Sperling RA; Marshall GA;
    JAMA Netw Open; 2019 Aug; 2(8):e198964. PubMed ID: 31397865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter lesions may be an early marker for age-related cognitive decline.
    Morrison C; Dadar M; Villeneuve S; Collins DL
    Neuroimage Clin; 2022; 35():103096. PubMed ID: 35764028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
    Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
    Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
    Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
    J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
    Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
    J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    Donohue MC; Sperling RA; Petersen R; Sun CK; Weiner MW; Aisen PS;
    JAMA; 2017 Jun; 317(22):2305-2316. PubMed ID: 28609533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
    Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
    J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal complex atrophy in poststroke and mild cognitive impairment.
    Selnes P; Grambaite R; Rincon M; Bjørnerud A; Gjerstad L; Hessen E; Auning E; Johansen K; Almdahl IS; Due-Tønnessen P; Vegge K; Bjelke B; Fladby T
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1729-37. PubMed ID: 26036934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of functional hippocampal activity, amyloid deposition, and longitudinal memory decline to memory complaints in cognitively healthy older adults.
    Chen X; Farrell ME; Rundle MM; Chan MY; Moore W; Wig GS; Park DC
    Neurobiol Aging; 2021 Sep; 105():318-326. PubMed ID: 34147860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
    Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
    Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.
    Petersen RC; Wiste HJ; Weigand SD; Rocca WA; Roberts RO; Mielke MM; Lowe VJ; Knopman DS; Pankratz VS; Machulda MM; Geda YE; Jack CR
    JAMA Neurol; 2016 Jan; 73(1):85-92. PubMed ID: 26595683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.